DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹5,655 Cr | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹5,655 Cr |
| Mar2025 | ₹5,578 Cr |
| Mar2024 | ₹4,507 Cr |
| Mar2023 | ₹2,183 Cr |
| Mar2022 | ₹1,952 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,655 Cr | 1.38 | |
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | - | |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹103,168.9 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,468.0 Cr | 1.2% | 4.4% | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 3% |
6.1% |
-3.8% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses